Synedica Retatrutide Pen — Advanced Triple-Incretin Formula

High-dose Synedica Retatrutide Pen activating GLP-1, GIP and Glucagon receptors for maximum metabolic research impact.

Concentration & Quality

• 40 mg Retatrutide per prefilled pen
• Triple hormone pathway activation
• Synedica pharmaceutical quality standard

Key Features

• Highest dose Retatrutide pen for advanced research
• Targets GLP-1, GIP, and Glucagon receptors simultaneously
• Extended duration of action for long-term studies

How to Use

Prefilled pen — store refrigerated (2–8 °C). For research use only.

How It Works

Retatrutide acts on three incretin pathways to suppress appetite, optimize glucose control and enhance fat metabolism. The 40 mg dose provides extended activity for intensive metabolic research.

Storage & Handling

Refrigerate at 2–8 °C. Protect from light and discard after expiry.